ID: ALA170509

Max Phase: Preclinical

Molecular Formula: C12H16N2

Molecular Weight: 188.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCc1nc2cc(C)c(C)cc2[nH]1

Standard InChI:  InChI=1S/C12H16N2/c1-4-5-12-13-10-6-8(2)9(3)7-11(10)14-12/h6-7H,4-5H2,1-3H3,(H,13,14)

Standard InChI Key:  CEBIUPNWQBWRSS-UHFFFAOYSA-N

Associated Targets(non-human)

Cytochrome P450 2B1 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 188.27Molecular Weight (Monoisotopic): 188.1313AlogP: 3.13#Rotatable Bonds: 2
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.03CX Basic pKa: 6.81CX LogP: 3.55CX LogD: 3.46
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.77Np Likeness Score: -1.46

References

1. Murray M, Ryan AJ, Little PJ..  (1982)  Inhibition of rat hepatic microsomal aminopyrine N-demethylase activity by benzimidazole derivatives. Quantitative structure-activity relationships.,  25  (8): [PMID:7120277] [10.1021/jm00350a002]

Source